Preliminary safety and efficacy of itolizumab, a novel targeted anti-cd6 therapy, in newly diagnosed severe acute graft-versus-host disease: interim results from the equate study

John Koreth, et. al., 2021

European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting 2021

Early reconstitution of cd6+ t cells after hematopoietic cell transplantation identifies a suitable target for acute graft-versus-host disease treatment using anti-cd6 monoclonal antibody itolizumab

Benedetta Rambaldi et. al., 2021

European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting 2021

Preliminary Safety and Efficacy of Itolizumab, A Novel Targeted Anti-CD6 Therapy, in Newly Diagnosed Severe Acute Graft-Versus-Host Disease: Interim Results from Equate Study

John Koreth et. al., 2021

TCT Meetings Digital Experience 2021

Impact of Itolizumab on the Expression of CD6 and the Function of Effector T Cells

Jeanette Ampudia et. al., 2020

American Society of Hematology Annual Meeting December 2020

Early Reconstitution of CD6+ T Cells after Hematopoietic Cell Transplantation Identifies a Suitable Target for Acute Graft Versus Host Disease Treatment Using Anti-CD6 Monoclonal Antibody Itolizumab

Benedetta Rambaldi et. al., 2020

American Society of Hematology Annual Meeting December 2020

CD6 Is Highly Expressed In Fatal Asthma Patients and May Modulate Bronchomotor Tone

Cynthia J. Koziol-White et. al., 2020

European Respiratory Society International Congress September 2020

CD6 Is Expressed On Human Airway and Blood ILCs and Is Upregulated by Epithelial Alarmins IL-33 and TSLP

Jana Badrani et. al., 2020

European Respiratory Society International Congress September 2020